Fatal pulmonary embolism or bleeding in patients with venous thromboembolism: implications of real-life data

Manuel Monreal

doi:10.1016/S0049-3848(19)30358-5

Fatal pulmonary embolism or bleeding in patients with venous thromboembolism: implications of real-life data

Manuel Monreal

Department of Medicine

Research output: Contribution to journal › Review article › Research › peer-review

5 Citations (Scopus)

Abstract

© 2019 Elsevier Ltd Reliable information on what patients with venous thromboembolism (VTE) are at increased risk to die of pulmonary embolism (PE) or bleeding (and the time course of the two fatal events) could likely help to better use anticoagulant therapy by improving selection of patients in whom its benefit will likely outweigh the risk. Unfortunately, there is scarce information in the literature on the incidence and time-course of fatal PE and fatal bleeding in real life clinical practice. This review article provides an overview of the most important published data on this topic using the RIETE (Registro Informatizado de Enfermedad Trombo Embólica) registry.

Original language	English
Pages (from-to)	S6-S9
Journal	Thrombosis Research
Volume	181
DOIs	https://doi.org/10.1016/S0049-3848(19)30358-5
Publication status	Published - 1 Sep 2019

Keywords

Anticoagulant therapy
Bleeding
Death
Pulmonary embolism
Venous thromboembolism

Access to Document

10.1016/S0049-3848(19)30358-5

Fingerprint Dive into the research topics of 'Fatal pulmonary embolism or bleeding in patients with venous thromboembolism: implications of real-life data'. Together they form a unique fingerprint.

Cite this

@article{536c8b43bb2c452f8887d665f5c5ada6,

title = "Fatal pulmonary embolism or bleeding in patients with venous thromboembolism: implications of real-life data",

abstract = "{\textcopyright} 2019 Elsevier Ltd Reliable information on what patients with venous thromboembolism (VTE) are at increased risk to die of pulmonary embolism (PE) or bleeding (and the time course of the two fatal events) could likely help to better use anticoagulant therapy by improving selection of patients in whom its benefit will likely outweigh the risk. Unfortunately, there is scarce information in the literature on the incidence and time-course of fatal PE and fatal bleeding in real life clinical practice. This review article provides an overview of the most important published data on this topic using the RIETE (Registro Informatizado de Enfermedad Trombo Emb{\'o}lica) registry.",

keywords = "Anticoagulant therapy, Bleeding, Death, Pulmonary embolism, Venous thromboembolism",

author = "Manuel Monreal",

year = "2019",

month = sep,

day = "1",

doi = "10.1016/S0049-3848(19)30358-5",

language = "English",

volume = "181",

pages = "S6--S9",

journal = "Thrombosis Research",

issn = "0049-3848",

publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Fatal pulmonary embolism or bleeding in patients with venous thromboembolism: implications of real-life data

AU - Monreal, Manuel

PY - 2019/9/1

Y1 - 2019/9/1

N2 - © 2019 Elsevier Ltd Reliable information on what patients with venous thromboembolism (VTE) are at increased risk to die of pulmonary embolism (PE) or bleeding (and the time course of the two fatal events) could likely help to better use anticoagulant therapy by improving selection of patients in whom its benefit will likely outweigh the risk. Unfortunately, there is scarce information in the literature on the incidence and time-course of fatal PE and fatal bleeding in real life clinical practice. This review article provides an overview of the most important published data on this topic using the RIETE (Registro Informatizado de Enfermedad Trombo Embólica) registry.

AB - © 2019 Elsevier Ltd Reliable information on what patients with venous thromboembolism (VTE) are at increased risk to die of pulmonary embolism (PE) or bleeding (and the time course of the two fatal events) could likely help to better use anticoagulant therapy by improving selection of patients in whom its benefit will likely outweigh the risk. Unfortunately, there is scarce information in the literature on the incidence and time-course of fatal PE and fatal bleeding in real life clinical practice. This review article provides an overview of the most important published data on this topic using the RIETE (Registro Informatizado de Enfermedad Trombo Embólica) registry.

KW - Anticoagulant therapy

KW - Bleeding

KW - Death

KW - Pulmonary embolism

KW - Venous thromboembolism

U2 - 10.1016/S0049-3848(19)30358-5

DO - 10.1016/S0049-3848(19)30358-5

M3 - Review article

VL - 181

SP - S6-S9

JO - Thrombosis Research

JF - Thrombosis Research

SN - 0049-3848

ER -